Inteum Company
Links
seedsprint
Visible Legacy
RSS
News & Resources
Inteum Company News
Inteum Library
Subscribe
Search Results - loic+deleyrolle
4
Results
Sort By:
Published Date
Updated Date
Title
ID
Descending
Ascending
Metabolic Enhancement of T Cells for Effective Immunotherapy in Tumor Microenvironments
Enhancing Metabolic Fitness of T -Cells to Treat Central Nervous System Tumors This T cell-based immunotherapy aims to enhance anti-tumor immune response by addressing metabolic restrictions within tumor microenvironments. T cells play a crucial role in targeting immune responses and adaptive immunity. However, their ability to respond to cancer cells...
Published: 12/23/2024
|
Inventor(s):
Loic Deleyrolle
,
Duane Mitchell
,
Jianping Huang
,
Linchun Jin
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Therapeutics
Natural Compounds for the Non-Toxic Treatment of Cancer
Administration of Non-Toxic Compounds, in Combination with a Low Carbohydrate Diet, Aids in Cancer Treatment Without Negative Side Effects This technology consists of natural compounds, which in combination with the implementation of a low carbohydrate diet, serve as a non-toxic aid in cancer treatment. Cancer is an energetically inefficient metabolic...
Published: 1/30/2024
|
Inventor(s):
Brent Reynolds
,
Loic Deleyrolle
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Nutraceutical
Nutritional Formulation for Managing the Negative Side Effects of Cancer Treatment
Lessens Chemotherapeutic Side Effects through the Consumption of Natural Products This natural formulation, optionally paired with a carbohydrate-limited diet, lessens the cytotoxic side effects of chemotherapy. Cancer management entails a combination of treatments, often employing surgery followed by chemotherapy, both targeted and non-targeted, with...
Published: 11/17/2023
|
Inventor(s):
Brent Reynolds
,
Loic Deleyrolle
Keywords(s):
Category(s):
Technology Classifications > Human Health Care > Nutraceutical
Nanoparticle RNA Vaccine That Targets Slow-Cycling, Treatment-Resistant Cancer
Activates T-Cell Recognition of Tumor-Initiating Stem Cells in Mouse Model of Glioma This nanoparticle vaccine targets the slow-cycling, treatment-resistant, cancer stem cells to improve efficiency of anti-cancer drugs, thereby improving disease prognosis. Despite major developments in the field of anti-cancer therapies, tumor recurrence and metastasis...
Published: 2/13/2024
|
Inventor(s):
Elias Sayour
,
Loic Deleyrolle
,
Hector Mendez-Gomez
,
Sadeem Qdaisat
,
Duane Mitchell
Keywords(s):
Cancer
,
cancer stem cells
,
Immunotherapy
,
Nanoparticles
,
Vaccine development
Category(s):
Technology Classifications > Human Health Care > Therapeutics